Zhi-Hao Li, Wen-Fang Zhong, Cheng-Shen Qiu, Pei Yang, Wei-Qi Song, Dong Shen, Xi-Ru Zhang, Dan Liu, Ying-Jun Chen, Pei-Liang Chen, Qing-Mei Huang, Qing Chen, Xiao-Meng Wang, Vincent C H Chung, Xiang Gao, Virginia Byers Kraus, Si-De Liu, Chen Mao
BACKGROUND: Proton pump inhibitors (PPIs) are widely prescribed for gastroesophageal reflux disease and peptic ulcer disease. However, the association between the regular PPIs use and the risk of cardiovascular disease (CVD) outcomes remains unclear. We aimed to determine whether regular proton pump inhibitors (PPIs) use is associated with an altered incidence of cardiovascular disease (CVD) in the general population. METHODS: This prospective cohort study included 459,207 participants (mean [SD] age, 56...
January 15, 2024: International Journal of Cardiology